Clinical Trial

A Single Ascending Dose Study of SYH2082 Injection in Healthy Participants

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
To evaluate the safety and tolerability of single dose of SYH2082 Injection in healthy participants.
Trial Details
NCT Number NCT07532655
Lead Sponsor CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Conditions Overweight or Obesity
Enrollment 44 participants
Start Date 2026-04-14
Primary Completion 2026-10-28 (estimated)
Study Completion 2027-02-09 (estimated)
Updated on ClinicalTrials.gov 2026-04-16